Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. 08/06/2018 INTERVENTIONAL not-comparable 2,987.75 0 Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC 08/06/2018 INTERVENTIONAL not-comparable 2,987.75 0 Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer 08/06/2018 INTERVENTIONAL not-comparable 2,987.75 0 Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer 08/07/2018 OBSERVATIONAL not-comparable 2,986.75 0 Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System 08/08/2018 INTERVENTIONAL not-comparable 2,985.75 0 PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer 08/09/2018 OBSERVATIONAL not-comparable 2,984.75 0 Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization 08/09/2018 OBSERVATIONAL not-comparable 2,984.75 0 Comparative Antiresorptive Efficacy Discontinuation of Denosumab 08/09/2018 INTERVENTIONAL not-comparable 2,984.75 0 Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS) 08/10/2018 INTERVENTIONAL not-comparable 2,983.75 0 CFI-400945 in Patients With Advanced/Metastatic Breast Cancer 08/10/2018 INTERVENTIONAL not-comparable 2,983.75 0 Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms 08/10/2018 OBSERVATIONAL not-comparable 2,983.75 0 Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection 08/10/2018 OBSERVATIONAL not-comparable 2,983.75 0 Maternal Outcomes Following Manual Lysis of the Placenta. 08/13/2018 INTERVENTIONAL not-comparable 2,980.75 0 Maternal Grandmothers in the Born in Guangzhou Cohort Study 08/16/2018 OBSERVATIONAL not-comparable 2,977.75 0 Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS 08/16/2018 INTERVENTIONAL not-comparable 2,977.75 0 Multidisciplinary Treatment of Chronic Vulvar Pain 08/21/2018 INTERVENTIONAL not-comparable 2,972.75 0 Post-operative Emesis and Pain Outcomes After Cesarean Delivery 08/24/2018 OBSERVATIONAL not-comparable 2,969.75 0 Improving Sleep Quality During Pregnancy Using an Oral Appliance 08/24/2018 INTERVENTIONAL not-comparable 2,969.75 0 Partial Breast Versus no Irradiation for Women With Early Breast Cancer 08/24/2018 INTERVENTIONAL not-comparable 2,969.75 0 Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients 08/29/2018 INTERVENTIONAL not-comparable 2,964.75 0 Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib 08/29/2018 INTERVENTIONAL not-comparable 2,964.75 0 Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone 09/07/2018 INTERVENTIONAL not-comparable 2,955.75 0 Investigating the Structured Use of Ultrasound Scanning for Fetal Growth 09/07/2018 OBSERVATIONAL not-comparable 2,955.75 0 Intravenous Estrogen in Kidney Transplant Study 09/10/2018 INTERVENTIONAL not-comparable 2,952.75 0 Postpartum Low-Dose Aspirin and Preeclampsia 09/12/2018 INTERVENTIONAL not-comparable 2,950.75 0 AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma 09/12/2018 INTERVENTIONAL not-comparable 2,950.75 0 A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients 09/14/2018 INTERVENTIONAL not-comparable 2,948.75 0 Laser Vaginal Treatment for SUI 09/14/2018 INTERVENTIONAL not-comparable 2,948.75 0 Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy 09/14/2018 INTERVENTIONAL not-comparable 2,948.75 0 My Personalized Breast Screening 09/14/2018 INTERVENTIONAL not-comparable 2,948.75 0 Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1 09/17/2018 INTERVENTIONAL not-comparable 2,945.75 0 Ribociclib and Letrozole Treatment in Ovarian Cancer 09/17/2018 INTERVENTIONAL not-comparable 2,945.75 0 Fetoscopic Endoluminal Tracheal Occlusion 09/17/2018 INTERVENTIONAL not-comparable 2,945.75 0 Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship 09/17/2018 OBSERVATIONAL not-comparable 2,945.75 0 RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer 09/18/2018 INTERVENTIONAL not-comparable 2,944.75 0 Dietary Management of Gestational Diabetes 09/21/2018 INTERVENTIONAL not-comparable 2,941.75 0 Preoperative Virtual Reality to Reduce Pain on Gynaecologic Patients Undergoing Surgery 09/26/2018 INTERVENTIONAL not-comparable 2,936.75 0 An Ultrasound Guided Automated Spinal Landmark Identification System 09/27/2018 INTERVENTIONAL not-comparable 2,935.75 0 Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH) 09/28/2018 INTERVENTIONAL not-comparable 2,934.75 0 Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP 10/02/2018 OBSERVATIONAL not-comparable 2,930.75 0 mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal 10/09/2018 INTERVENTIONAL not-comparable 2,923.75 0 Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia 10/11/2018 INTERVENTIONAL not-comparable 2,921.75 0 Tocotrienols for Obesity of Postmenopausal Women 10/15/2018 INTERVENTIONAL not-comparable 2,917.75 0 A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors 10/16/2018 INTERVENTIONAL not-comparable 2,916.75 0 PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). 10/19/2018 INTERVENTIONAL not-comparable 2,913.75 0 Robot-assisted Approach to Cervical Cancer 10/25/2018 INTERVENTIONAL not-comparable 2,907.75 0 Exploring Respiratory Health Outcomes From Sustained Use of Efficient Cookstoves 11/01/2018 INTERVENTIONAL not-comparable 2,900.75 0 A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer 11/02/2018 INTERVENTIONAL not-comparable 2,899.75 0 Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy 11/05/2018 INTERVENTIONAL not-comparable 2,896.75 0 Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment 11/06/2018 INTERVENTIONAL not-comparable 2,895.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology